{"id":"W4390572101","doi":"10.1182/bloodadvances.2023011735","title":"Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Astellas Pharma; Leukemia and Lymphoma Society of Canada; Celgene; Sierra Oncology; Leukemia and Lymphoma Society; Princess Margaret Cancer Foundation; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Cytarabine; Internal medicine; Daunorubicin; Gastroenterology; Myeloid leukemia; Confidence interval; Retrospective cohort study; Odds ratio; Myeloid; Hypomethylating agent; Oncology; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001009033,0.0001325663,0.0003750755,0.0001710451,0.0001705396,0.0003101912,0.0001750614,0.0002551244,0.0008059177],"category_scores_gemma":[0.001803075,0.00006901631,0.0003035146,0.0002038685,0.0002120329,0.0002681342,0.0003677519,0.0005340119,0.0001580403],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003405629,"about_ca_system_score_gemma":0.0002172946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002464564,"about_ca_topic_score_gemma":0.0003965638,"domain_scores_codex":[0.9995345,0.0001907169,0.00005677231,0.00006302987,0.00007510765,0.00007998173],"domain_scores_gemma":[0.9983205,0.0005096692,0.0005956631,0.0001072765,0.0000922271,0.0003745976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05306864,0.003271843,0.8104441,0.0001818558,0.000575864,0.0014914,0.0004862274,0.002428848,0.01217788,0.0002384011,0.0007966125,0.1148384],"study_design_scores_gemma":[0.001168353,0.04344063,0.945224,0.00004008709,0.0002417162,0.002704216,0.0002433833,0.001431326,0.003834942,0.0002545498,0.001398511,0.00001827984],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991522,0.000319384,0.00009071417,0.00002147165,0.000002861964,0.00002231856,0.00005837002,0.000001820645,0.0003308855],"genre_scores_gemma":[0.999575,0.00006075727,0.00004420207,0.00003046496,0.00000895348,0.00001808974,0.0001773253,0.000001048146,0.00008425897],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001009033,"threshold_uncertainty_score":0.005336344,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02021642297003689,"score_gpt":0.3423091176300899,"score_spread":0.322092694660053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}